Alkalization in patients with metabolic acidosis in the course of chronic kidney disease

Journal Title: Annales Academiae Medicae Silesiensis - Year 2017, Vol 71, Issue

Abstract

Chronic kidney disease in different stages affects >10% of the general population. Its societal importance is under-scored by the ever growing number of patients with end-stage kidney disease requiring renal replacement therapy. A common complication of chronic renal failure is metabolic acidosis which has a row of negative clinical sequelae including acceleration of the progression of chronic nephropathies. The aim of this work was to present the issue of oral alkalization in patients with chronic kidney disease, especially in the context of slowing down the course of chronic kidney disease. The studies in animals and human subjects are quite optimistic in this regard and may have clinical and economic implications. Nevertheless, their relevance is limited by the relatively small numbers of subjects and variable stages of chronic kidney disease studied. In addition, the study durations, types of alkalinizing agents and control group characteristics were inconsistent among the studies. Ongoing clinical trials should be able to provide conclusions in the matter of long-term alkalizing treatment and nephroprotection. Positive outcomes would translate not only into improved patient prognoses with the use of a relatively inexpensive therapeutic option, but also into alleviation of the health care cost burden imposed on the society.

Authors and Affiliations

Beata Łącka-Gaździk, Magdalena Żak-Lenart, Mirosław Śnit, Władysław Grzeszczak

Keywords

Related Articles

Gitelman syndrome with early onset – a case report and literature news

INTRODUCTION: Gitelman syndrome (GS) is caused by genetic mutation resulting in dysfunction of the thiazide-sensitive sodium-chloride cotransporter located in the distal convoluted tubule. The disease usually produces th...

Komputerowo wspomagana lokalizacja jądra niskowzgórzowego (STN) w przebiegu operacji głębokiej stymulacji mózgu (DBS) u pacjentów z chorobą Parkinsona

W S T Ę P Podczas zabiegu głębokiej stymulacji mózgu (deep brain stimulation – DBS) stosowanego w leczeniu choroby Parkinsona celem operacji jest mała (9 x 7 x 4 mm) głęboko położona struktura mózgu nazywana jądrem nisko...

The role of suPAR in kidney diseases

Chronic kidney disease (CKD) is unquestionably a problem of social significance because it affects about 10% of the population. There is a search for biomarkers which could help select persons out of such a large group o...

Hiperkalcemia w wybranych nowotworach limfo- i mieloproliferacyjnych – patofizjologia, diagnostyka i leczenie

Hiperkalcemia jest poważnym powikłaniem metabolicznym rozwijającym się w przebiegu wielu chorób nowotworo-wych – w hematologii najczęściej spotykana jest w szpiczaku plazmocytowym, rzadziej w chłoniakach niehodgkinow-ski...

Water reservoirs as areas of intensified occurrences of life and health threatening conditions during summer season and their medical safeguarding on example of one of most-attractive tourist reservoirs in Silesian province – Pogoria III in Dąbrowa Górnicza

INTRODUCTION During the summer season, areas surrounding water reservoirs and beaches are repeatedly crowded with thousands of people. Such concentrations are predisposed to increased incidence of sudden health deteriora...

Download PDF file
  • EP ID EP361835
  • DOI 10.18794/aams/63516
  • Views 117
  • Downloads 0

How To Cite

Beata Łącka-Gaździk, Magdalena Żak-Lenart, Mirosław Śnit, Władysław Grzeszczak (2017). Alkalization in patients with metabolic acidosis in the course of chronic kidney disease. Annales Academiae Medicae Silesiensis, 71(), 331-338. https://europub.co.uk./articles/-A-361835